A Membrane Vesicle/ribosome Preparation from Serratia Marcescens Elicits Peritoneal Exudate Cells Expressing Both Tumoricidal and Bactericidal Activity

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 1992 Aug 1

PMID 1526665

Authors

C McCall

L Weimer

S Baldwin

D W Riches

B Canono

P A Campbell

Affiliations

Soon will be listed here.

Abstract

A biological response modifier called ImuVert, derived from the bacterium Serratia marcescens, produced long-lasting elevation of peritoneal exudate cell (PEC) numbers after intraperitoneal injection into mice. These cells had enhanced ability to phagocytose both latex beads and opsonized Listeria monocytogenes. PEC harvested 2-14 days after a single injection of ImuVert killed L. monocytogenes, and ImuVert protected mice from infection by L. monocytogenes, measured both by LD50 and bacterial growth in vivo. Cells harvested 7 and 14 days after ImuVert injection also were tumoricidal, measured as killing of P815 mastocytoma cells, and ImuVert induced macrophages to express tumoricidal properties in vitro. These data suggest that ImuVert has a unique ability to induce a chronic inflammatory response, as other agents do not induce such a long-lasting influx of bactericidal inflammatory cells that also show tumoricidal activity. The consequences of this response appear to include protection from infection by certain bacteria.

References

Riches D, Henson P, Remigio L, Catterall J, Strunk R . Differential regulation of gene expression during macrophage activation with a polyribonucleotide. The role of endogenously derived IFN. J Immunol. 1988; 141(1):180-8. View

Campbell P, Czuprynski C, Cook J . Differential expression of macrophage effector functions: bactericidal versus tumoricidal activities. J Leukoc Biol. 1984; 36(3):293-306. DOI: 10.1002/jlb.36.3.293. View

Havell E . Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol. 1989; 143(9):2894-9. View

Nakane A, Minagawa T, KOHANAWA M, Chen Y, Sato H, Moriyama M . Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun. 1989; 57(11):3331-7. PMC: 259813. DOI: 10.1128/iai.57.11.3331-3337.1989. View

Baker L, Campbell P . Thioglycolate medium decreases resistance to bacterial infection in mice. Infect Immun. 1980; 27(2):455-60. PMC: 550787. DOI: 10.1128/iai.27.2.455-460.1980. View

Warren R, McCall C, Urban R . Augmentation of ADCC and cytotoxic T-cell activity with ImuVert. Mol Biother. 1989; 1(6):323-7. View

Stevenson M, Kongshavn P, Skamene E . Genetic linkage of resistance to Listeria monocytogenes with macrophage inflammatory responses. J Immunol. 1981; 127(2):402-7. View

Drevets D, Campbell P . Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun. 1991; 59(8):2645-52. PMC: 258068. DOI: 10.1128/iai.59.8.2645-2652.1991. View

Wing E, Gardner I, Ryning F, Remington J . Dissociation of effector functions in populations of activated macrophages. Nature. 1977; 268(5621):642-4. DOI: 10.1038/268642a0. View

10.

Riches D, Henson P . Bacterial lipopolysaccharide suppresses the production of catalytically active lysosomal acid hydrolases in human macrophages. J Cell Biol. 1986; 102(5):1606-14. PMC: 2114209. DOI: 10.1083/jcb.102.5.1606. View

11.

Young K, Czuprynski C . Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes. Infect Immun. 1989; 57(10):3014-21. PMC: 260764. DOI: 10.1128/iai.57.10.3014-3021.1989. View

12.

Czuprynski C, Brown J, Young K, Cooley A, Kurtz R . Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection. J Immunol. 1988; 140(3):962-8. View

13.

ALFORD C, King Jr T, Campbell P . Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity. J Exp Med. 1991; 174(2):459-66. PMC: 2118915. DOI: 10.1084/jem.174.2.459. View

14.

Czuprynski C, Henson P, Campbell P . Killing of Listeria monocytogenes by inflammatory neutrophils and mononuclear phagocytes from immune and nonimmune mice. J Leukoc Biol. 1984; 35(2):193-208. DOI: 10.1002/jlb.35.2.193. View

15.

House R, Pearson F, Thomas P . Selective potentiation of host resistance in mice following treatment with Pyrexol. Mol Biother. 1990; 2(3):175-8. View

16.

Campbell P, Canono B, Cook J . Mouse macrophages stimulated by recombinant gamma interferon to kill tumor cells are not bactericidal for the facultative intracellular bacterium Listeria monocytogenes. Infect Immun. 1988; 56(5):1371-5. PMC: 259835. DOI: 10.1128/iai.56.5.1371-1375.1988. View

17.

Tilney L, Portnoy D . Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol. 1989; 109(4 Pt 1):1597-608. PMC: 2115783. DOI: 10.1083/jcb.109.4.1597. View

18.

Czuprynski C, Henson P, Campbell P . Enhanced accumulation of inflammatory neutrophils and macrophages mediated by transfer of T cells from mice immunized with Listeria monocytogenes. J Immunol. 1985; 134(5):3449-54. View

19.

Campbell P . Are inflammatory phagocytes responsible for resistance to facultative intracellular bacteria?. Immunol Today. 2014; 7(3):70-2. DOI: 10.1016/0167-5699(86)90086-1. View

20.

Nowotny A, Keler T, Pham P, Kovats E, Aiello A, Shonekan O . Isolation of a nonendotoxic antitumor preparation from Serratia marcescens. J Biol Response Mod. 1988; 7(3):296-308. View